Mortality in COVID-19 amongst women on Hormone Replacement Therapy or Combined Oral Contraception: A cohort study

Hajira Dambha-Miller, William Hinton, Mark Joy, Michael Feher, Simon de Lusignan
doi: https://doi.org/10.1101/2021.02.16.21251853

Article Information

doi 
https://doi.org/10.1101/2021.02.16.21251853
History 
  • February 19, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Hajira Dambha-Miller1,*,
  2. William Hinton2,
  3. Mark Joy2,
  4. Michael Feher2 and
  5. Simon de Lusignan2,3
  1. 1Primary Care Research Centre, University of Southampton
  2. 2Nuffield Department of Primary Care Health Sciences, University of Oxford
  3. 3Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), London, UK
  1. ↵*Correspondence:
    Dr Hajira Dambha-Miller, Primary Care and Population Health, University of Southampton, Southampton, SO16 5ST, Email: H.Dambha-Miller{at}soton.ac.uk
Back to top
Posted February 19, 2021.
Download PDF
Data/Code
Email
Mortality in COVID-19 amongst women on Hormone Replacement Therapy or Combined Oral Contraception: A cohort study
Hajira Dambha-Miller, William Hinton, Mark Joy, Michael Feher, Simon de Lusignan
medRxiv 2021.02.16.21251853; doi: https://doi.org/10.1101/2021.02.16.21251853
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area